Jeffrey H Cooper's Net Worth

$11.6 Million

Estimate Recalculated Sep 17, 2024 04:55PM EST

Who is Jeffrey H Cooper?

Jeffrey H Cooper has an estimated net worth of $11.6 Million. This is based on reported shares across multiple companies, which include BIOMARIN PHARMACEUTICAL INC, Sierra Oncology, Inc., KALOBIOS PHARMACEUTICALS INC, and Regado Biosciences Inc.

SEC CIK

Jeffrey H Cooper's CIK is 0001301173

Past Insider Trading and Trends

2011 was Jeffrey H Cooper's most active year for acquiring shares with 12 total transactions. Jeffrey H Cooper's most active month to acquire stocks was the month of April. 2008 was Jeffrey H Cooper's most active year for disposing of shares, totalling 40 transactions. Jeffrey H Cooper's most active month to dispose stocks was the month of January. 2007 saw Jeffrey H Cooper paying a total of $1,585,215.96 for 138,916 shares, this is the most they've acquired in one year. In 2012 Jeffrey H Cooper cashed out on 224,072 shares for a total of $6,129,489.49, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7

SVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.46%
985
$30.68
-$351,533.64
41.09K
Scheduled
Apr 30 - May 14
Form 4
—
0
$26.82
-$1,370,188.92
40.1K
Feb 24
Form 4
-11.09%
-5.00K
$24.57
-$122,855.00
40.1K
Scheduled
Jan 3
Form 4
-11.97%
-4.77K
$18.52
-$116,104.47
40.1K
Scheduled
Oct 31 - Nov 1
Form 4
—
0
$25.77
-$302,518.34
39.88K
Scheduled
Oct 10
Form 4
—
0
$24.77
-$265,760.34
39.88K
Scheduled
Sep 28
Form 4
—
0
$21.90
-$37,538.00
39.88K
Scheduled
Sep 1
Form 4
—
0
$23.90
-$236,993.04
39.88K
Aug 2
Form 4
—
0
$23.77
-$228,989.88
39.88K
Scheduled
Jul 14
Form 4
—
0
$20.95
-$32,775.00
39.88K
Scheduled
Jul 1
Form 4
+5.28%
2K
—
—
39.88K
Jun 7
Form 4
-48.03%
-35.00K
$20.95
-$733,075.00
37.88K
Scheduled
May 26
Form 4
+5.57%
2K
—
—
37.88K
May 20
Form 4
+33.82%
9.07K
$11.64
—
35.88K
Apr 29 - May 12
Form 4
-83.73%
-22.18K
$16.30
-$467,492.27
26.81K
Scheduled
Oct 29 - Nov 24
Form 4
—
0
$18.53
-$390,340.00
26.49K
Scheduled
Oct 29
Form 4
—
0
$15.02
-$273,214.65
26.49K
Scheduled
Oct 25
Form 4
-18.47%
-6.00K
$22.85
-$137,106.00
26.49K
Sep 13
Form 4
+14.04%
4K
—
—
32.49K
May 22 - Jun 7
Form 4
+53.28%
9.9K
$11.64
—
28.49K
May 12 - May 30
Form 4
+12.12%
2K
—
—
18.5K
Jun 22
Form 4
+13.79%
2K
—
—
16.5K
Jun 7
Form 4
+187.40%
9.46K
$10.93
—
14.5K
Apr 30 - May 12
Form 4
—
0
—
—
0
Dec 17
Form 4
+305.47%
3.07K
$13.95
—
4.08K
Apr 30 - Jul 7
Form 4
—
0
—
—
0
May 22
Form 4
-85.46%
-5.91K
$37.94
-$224,058.00
1K
Feb 29
Form 4
+587.56%
5.91K
$23.49
-$1,349,488.92
6.91K
Feb 29
Form 4
—
0
$17.05
-$221,602.00
0
Scheduled
Oct 8
Form 4
—
0
$16.30
-$205,000.00
0
Scheduled
Sep 26
Form 4
—
0
$15.30
-$194,918.40
0
Scheduled
Sep 6
Form 4
—
0
$13.47
-$272,708.94
0
Aug 17
Form 4
—
0
$14.55
-$161,250.00
0
Scheduled
Aug 8
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
$13.05
-$143,550.00
0
Scheduled
Dec 6
Form 4
—
0
—
—
0
Nov 20
Form 4
—
0
$11.83
-$217,220.00
0
Scheduled
Aug 29
Form 4
—
0
$11.48
-$84,375.00
0
Scheduled
Mar 16
Form 4
—
0
$9.63
-$112,320.00
0
Scheduled
Mar 1
Form 4
—
0
$9.20
-$8,100.00
0
Scheduled
Feb 27
Form 4
—
0
—
—
0
Jan 6
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Aug 19
Form 3
—
0
—
—
0
No matching records found

Sierra Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
No matching records found

KALOBIOS PHARMACEUTICALS INC (HGEN) Snapshot price: $0.0002

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 30
Form 3
—
0
—
—
0
No matching records found

Regado Biosciences Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found